Marketing-authorisation holder
Similasan AG
1 medicine in 1 country, as authorisation holder and manufacturer.
Medicines
Every medicine in the registers under its name, current ones first.
1 medicine
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| SIMILASAN EYE DROPS NO230.148 ml / 100 ml + 30.148 ml / 100 ml + 30.148 ml / 100 ml · Liquid | Apis mellifica, Euphrasia officinalis, Sabadilla | Canada | Cancelled | 1996 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 1 | 0 | 1 | CompaniesAll medicines |
Also in the registers of Brazil
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- similasan
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 1
- Countries
- 1
- Roles
- Authorisation holder and manufacturer